Company: EDSA
Filing Date: 2025-04-04
Form Type: 8-K
Source: 0001171843-25-002027
Chunk: 1

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are filed as part of this Current Report on Form 8-K:

  Exhibit Number      Description                                                                              
  10.1*               Employment Agreement, dated April 3, 2025, by and between the Company and Peter Weiler.  
  99.1                Press Release, dated April 4, 2025.                                                      
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104                 Cover Page Interactive Data File (embedded within the Inline XBRL document)              

* Management contract or compensatory plan or arrangement.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  EDESA BIOTECH, INC.                                                                 
  By:                      /s/ Pardeep Nijhawan                                       
                           Pardeep Nijhawan                                           
                           Director, Chief Executive Officer and Corporate Secretary